Recent Updates
Recently added Catalysts
VNRX Positive Sentiment

Nanopore sequencing to elucidate the origins of circulating DNA during extracorporeal membrane oxygenation

Monday, October 7, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: The article discusses a poster presentation titled 'Nanopore sequencing to elucidate the origins of circulating DNA during extracorporeal membrane oxygenation' by Berman et al. at the ESICM 2024 conference. The research aims to explore the role of nanopore sequencing in understanding circulating DNA, which may have implications for patient management during ECMO procedures.
Price reaction · baseline $17.734 (2024-10-07T15:11:00.000Z) · hit during market hours · 5 other VNRX headline(s) in the window, move may be shared
day 0 close
-11.5%
day 1
-12.8%
day 3 · peak
-21.1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Presentation at a significant conference (ESICM 2024).
  • Focus on innovative nanopore sequencing technology.
  • Potential insights into circulating DNA origins during ECMO.

Full Press Release Details

Poster titled: Nanopore sequencing to elucidate the origins of circulating DNA during extracorporeal membrane oxygenation.
Presented at: ESICM 2024
Berman et al

Related Articles

• Press Releases Data Showing the Prognostic Value of its Nu.Q® Cancer Test
• Poster & Publications Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

Data Showing the Prognostic Value of its Nu.Q® Cancer Test

Cytokine-induced chromatin accessibility in whole blood neutrophils links to sepsis transcriptional states

• Share
• Tweet
• Share on Facebook
• Share

Subscribe for Volition product updates .

Or, click here for Investor Updates and press releases .

" * " indicates required fields

Frequently Asked Questions

What was the focus of the poster presented?

The poster focused on nanopore sequencing to understand circulating DNA origins during ECMO.

Where was the research presented?

The research was presented at the ESICM 2024 conference.

Who conducted the research on nanopore sequencing?

The research was conducted by Berman et al.

What technology is being explored in the study?

The study explores nanopore sequencing technology.

ShareAdd on Google
Tags: VNRX Viatris Investor Conferences Healthcare nanopore sequencing circulating DNA ECMO ESICM 2024
Last updated: Oct 7, 2024

Biotech snapshot

Cash runway
$3M liquidity · $2M/mo burn
~1 mo
High dilution risk